¼¼°èÀÇ STD °Ë»ç ½ÃÀå
STD Testing
»óǰÄÚµå : 1763179
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 197 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ STD °Ë»ç ½ÃÀåÀº 2030³â±îÁö 1,448¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 1,070¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ STD °Ë»ç ½ÃÀåÀº 2030³â¿¡´Â 1,448¾ï ´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ 2024-2030³â CAGRÀº 5.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀΠŬ¶ó¹Ìµð¾Æ´Â CAGR 5.0%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 406¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´Ü¼ø Ç츣Æä½º ¹ÙÀÌ·¯½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 6.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 284¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ STD °Ë»ç ½ÃÀåÀº 2024³â¿¡ 284¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 315¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 8.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.8%¿Í 4.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ STD °Ë»ç ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼ºº´ °Ë»ç°¡ Àü ¼¼°è¿¡¼­ ½Ã±ÞÈ÷ ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¼¼°è¿¡¼­ ¼ºº´(STD)ÀÇ À¯ÇàÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼ºº´ °Ë»ç ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ºÇൿÀÇ º¯È­, ÀÎ½Ä ºÎÁ·, ¾ÈÀüÇÑ ¼º»ýȰ¿¡ ´ëÇÑ ºÒÃæºÐÇÑ ±³À° µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºº´ ȯÀÚ°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÀÇ·á ±â°ü°ú Á¤ºÎ´Â °¨¿° È®»êÀ» ¾ïÁ¦Çϰí ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ Á¶±â Áø´Ü°ú Á¤±âÀûÀÎ °Ë»ç¸¦ Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­´Â °øÁߺ¸°Ç Ä·ÆäÀÎÀÇ È®´ë¿Í ÀÇ·á ¼­ºñ½º Á¢±Ù¼º Çâ»óµµ ¼ºº´ °Ë»çÀÇ Á߿伺¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, HIV, Ŭ¶ó¹Ìµð¾Æ, ÀÓÁú, ¸Åµ¶°ú °°Àº Áúº´Àº °øÁߺ¸°ÇÀÇ ÁÖ¿ä °ü½É»çÀ̱⠶§¹®¿¡ Á¢±ÙÀÌ ¿ëÀÌÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖÀ¸¸ç ½Å¼ÓÇÑ °Ë»ç ¼Ö·ç¼ÇÀÇ Á߿伺Àº Àü ¼¼°è¿¡¼­ °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è¿¡¼­ Á¾ÇÕÀûÀÎ °Ë»ç ÇÁ·Î±×·¥ÀÇ ½Ã±ÞÇÑ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¼ºº´ °Ë»ç »óȲ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

¼ºº´ °Ë»ç ½ÃÀåÀº Áø´ÜÀÇ ¼Óµµ, Á¤È®¼º, Á¢±Ù¼º Çâ»óÀ» À§ÇÑ ±â¼ú ¹ßÀüÀ¸·Î ÀçÆíµÇ°í ÀÖÀ¸¸ç, Á¶±â °³ÀÔ ¹× Ä¡·á¿¡ ÇʼöÀûÀÎ ½ÇÇè½Ç 󸮰¡ ÇÊ¿ä ¾øÀÌ ºü¸¥ °á°ú¸¦ Á¦°øÇÏ´Â POC(Point of Care) °Ë»ç Àåºñ°¡ Á¡Á¡ ´õ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR) °Ë»ç¿Í °°Àº ºÐÀÚÁø´Ü¹ýÀº ¼ºº´ °ËÃâÀÇ Á¤È®µµ¸¦ ³ôÀ̰í ÀÖÀ¸¸ç, ÇϳªÀÇ »ùÇÿ¡¼­ ¿©·¯ º´¿ø±ÕÀ» ½Äº°ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ Áý¿¡¼­ °³ÀÎÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ´Â ÀÚ°¡ °Ë»ç ŰƮµµ °³ÀÎÀÌ ÀÚ½ÅÀǼº °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖ´Â Æí¸®ÇÏ°í ´«¿¡ ¶çÁö ¾Ê´Â ¹æ¹ýÀ» Á¦°øÇÑ´Ù´Â Á¡¿¡¼­ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¿ø°Ý »ó´ã ¹× °á°ú ÇØ¼®À» À§ÇØ »ç¿ëÀÚ¸¦ ÀÇ·á Àü¹®°¡¿Í ¿¬°áÇØÁÖ´Â ¸ð¹ÙÀÏ Çコ(mHealth) Ç÷§ÆûÀÇ ÅëÇÕÀº ¼ºº´ °Ë»ç ¼­ºñ½ºÀÇ µµ´Þ ¹üÀ§¿Í È¿À²¼ºÀ» ´õ¿í ³ôÀ̰í ÀÖÀ¸¸ç, ƯÈ÷ ¿Üµý Áö¿ªÀ̳ª ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ¼ºº´ °Ë»ç ¼­ºñ½ºÀÇ µµ´Þ ¹üÀ§¿Í È¿À²¼ºÀ» ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù.

¼ºº´ °Ë»ç ¼­ºñ½º ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ½ÃÀå µ¿ÇâÀº ¹«¾ùÀΰ¡?

¼º °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í, ƯÈ÷ ÀþÀº ÃþÀÇ ¼ºº´ À¯º´·üÀÌ ³ô¾ÆÁö¸é¼­ ¼ºº´ °Ë»ç ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ û¼Ò³â, LGBTQ+ Ä¿¹Â´ÏƼ, ¼º³ëµ¿ÀÚ µî °íÀ§Ç豺À» ´ë»óÀ¸·Î ÇÑ ±³À° Ä·ÆäÀΰú °øÁߺ¸°Ç ±¸»óÀº Á¤±âÀûÀÎ °Ë»ç¿Í Á¶±â Áø´ÜÀÇ Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¿¹¹æ ¹× ¸ÂÃã ÀÇ·á·ÎÀÇ Àüȯµµ ÇѸòÀ» Çϰí ÀÖÀ¸¸ç, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº °¨¿° È®»êÀ» ¿ÏÈ­Çϱâ À§ÇØ Àû±ØÀûÀÎ °ËÁø ¹× Á¤±âÀûÀÎ °ËÁøÀ» ±ÇÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Æ¯È÷ COVID-19 ÆÒµ¥¹ÍÀ» °è±â·Î ¿ø°ÝÀÇ·á ¼Ö·ç¼ÇÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ¸é¼­ ¼ºº´ °Ë»ç ¹× Áø·á¿¡ ´ëÇÑ Æí¸®ÇÑ Á¢±Ù¼ºÀ» Á¦°øÇÏ´Â ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ È®´ë·Î °Ë»ç°¡ ´õ¿í Ä£¼÷ÇÏ°í ¸Å·ÂÀûÀ¸·Î ´Ù°¡¿À°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Á¾ÇÕÀûÀÎ ÇコÄɾîÀÇ ÀÏȯÀ¸·Î ÀÏ»óÀûÀÎ ¼ºº´ °Ë»ç°¡ ¹Þ¾Æµé¿©Áö°í ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

¼ºº´ °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¼ºº´ °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀº ¼ºº´ À¯º´·ü Áõ°¡, Áø´Ü ÅøÀÇ ±â¼ú ¹ßÀü, ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ °³ÀÎ ÇÁ¶óÀ̹ö½Ã¿Í Æí¸®ÇÔÀ» ¼±È£ÇÏ´Â °³ÀÎÀ» À§ÇØ ÇöÀå °Ë»ç ±â¼úÀÇ È®´ë¿Í °¡Á¤¿ë °Ë»ç ŰƮÀÇ °¡¿ë¼ºÀ¸·Î ÀÎÇØ °Ë»ç°¡ ´õ¿í Ä£¼÷ÇØÁ³½À´Ï´Ù. °Ë»ç °á°úÀÇ Á¤È®¼º°ú ½Å¼Ó¼ºÀ» ³ô¿©ÁÖ´Â ºÐÀÚÁø´ÜÀÇ ÅëÇÕÀº °¨¿°º´ °ü¸®¿Í È®»ê ¹æÁö¸¦ À§ÇÑ È¿À²ÀûÀÎ ¹æ¹ýÀ» ã´Â ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀ» ¸Å·á½Ã۰í ÀÖ½À´Ï´Ù. °øÁߺ¸°Ç ³ë·Â°ú ±³À° Ä·ÆäÀÎÀº ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÇ°í ÀÖ´Â °³¹ßµµ»ó±¹¿¡¼­ °Ë»ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ º¸±ÞÀ¸·Î ¿ø°Ý Áø·á ¹× °Ë»ç¿¡ ´ëÇÑ Á¢±ÙÀÌ ¿ëÀÌÇØÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÇÕÀûÀÎ ¿äÀεéÀÌ ¼ºº´ °Ë»ç ½ÃÀåÀÇ È®´ë¸¦ ÃËÁøÇϸç Çö´ë ÀÇ·áÀÇ Áß¿äÇÑ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Áúȯ À¯Çü(Ŭ¶ó¹Ìµð¾Æ, ´Ü¼ø Ç츣Æä½º ¹ÙÀÌ·¯½º, ÀÓÁú, ÀÎÀ¯µÎÁ¾¹ÙÀÌ·¯½º(HPV), ¸Åµ¶, ±âŸ Áúȯ À¯Çü), Àå¼Ò(½ÇÇè½Ç , POC(Point-of-Care))

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global STD Testing Market to Reach US$144.8 Billion by 2030

The global market for STD Testing estimated at US$107.0 Billion in the year 2024, is expected to reach US$144.8 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Chlamydia, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis period. Growth in the Herpes Simplex Virus segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.4 Billion While China is Forecast to Grow at 8.2% CAGR

The STD Testing market in the U.S. is estimated at US$28.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$31.5 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global STD Testing Market - Key Trends & Drivers Summarized

Why Is STD Testing Gaining Urgency and Attention Worldwide?

The rising prevalence of sexually transmitted diseases (STDs) across the globe has led to a significant increase in demand for STD testing services. Factors such as changing sexual behavior, lack of awareness, and inadequate education on safe practices have contributed to the surge in STD cases. In response, healthcare organizations and governments are promoting early diagnosis and routine testing to curb the spread of infections and improve patient outcomes. The expansion of public health campaigns and increased access to healthcare services, particularly in developing regions, are also contributing to the emphasis on STD testing. With diseases like HIV, chlamydia, gonorrhea, and syphilis being major public health concerns, the importance of accessible, reliable, and rapid testing solutions continues to grow, underscoring the urgent need for comprehensive testing programs worldwide.

How Are Technological Advancements Influencing the STD Testing Landscape?

The STD testing market is being reshaped by technological advancements aimed at improving diagnostic speed, accuracy, and accessibility. Point-of-care (POC) testing devices are becoming increasingly popular, offering rapid results without the need for laboratory processing, which is essential for early intervention and treatment. Molecular diagnostics, such as polymerase chain reaction (PCR) tests, are enhancing the precision of STD detection, allowing for the identification of multiple pathogens from a single sample. Self-testing kits, which can be used privately at home, are also gaining traction as they provide a convenient and discreet way for individuals to manage their sexual health. The integration of mobile health (mHealth) platforms that connect users with healthcare professionals for remote consultations and result interpretation is further enhancing the reach and efficiency of STD testing services, especially in remote or underserved areas.

What Are the Market Trends Influencing the Demand for STD Testing Services?

The increasing awareness of sexual health and the rising prevalence of STDs, particularly among the younger population, are significantly influencing the demand for STD testing services. Educational campaigns and public health initiatives, particularly those targeting at-risk groups like young adults, LGBTQ+ communities, and sex workers, are emphasizing the importance of regular testing and early diagnosis. The shift towards preventive healthcare and personalized medicine is also playing a role, as healthcare providers advocate for proactive screening and routine check-ups to mitigate the spread of infections. Additionally, the expansion of telemedicine services, which offer convenient access to STD testing and consultations, is making testing more accessible and appealing, particularly in the wake of the COVID-19 pandemic, which accelerated the adoption of remote healthcare solutions. These trends indicate a growing acceptance and demand for routine STD testing as part of comprehensive healthcare management.

What Factors Are Driving the Growth of the STD Testing Market?

The growth in the STD testing market is driven by several factors, including the rising prevalence of STDs, technological advancements in diagnostic tools, and the increasing emphasis on preventive healthcare. The expansion of point-of-care testing technologies and the availability of at-home testing kits are making testing more accessible, particularly for individuals who prefer privacy and convenience. The integration of molecular diagnostics, which enhances the accuracy and speed of test results, is attracting healthcare providers looking for efficient ways to manage and prevent the spread of infections. Public health initiatives and educational campaigns are also expanding testing access, particularly in developing regions where healthcare infrastructure is improving. Additionally, the widespread adoption of telemedicine services is facilitating remote consultations and access to testing, further supporting market growth. These combined factors are propelling the expansion of the STD testing market, making it a critical component of modern healthcare.

SCOPE OF STUDY:

The report analyzes the STD Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Type (Chlamydia, Herpes Simplex Virus, Gonorrhea, Human Papillomavirus (HPV), Syphilis, Other Disease Types); Location (Laboratory, Point-of-Care (POC))

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â